Intestinal Glucagon-like Peptide-1 (GLP-1) and the Physiological Role in Eating in Humans
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The aim is to further establish a physiological role for GLP-1 as an endogenous satiety
signal by examining the effect of the specific GLP-1 receptor antagonist exendin (9-39) on
appetite and food intake in healthy male subjects.